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Abstract The major reservoirs for HIV in the CNS are in the
microglia, perivascular macrophages, and to a lesser extent,
astrocytes. To study the molecular events controlling HIV
expression in the microglia, we developed a reliable and ro-
bust method to immortalize microglial cells from primary glia
from fresh CNS tissues and commercially available frozen
glial cells. Primary human cells, including cells obtained from
adult brain tissue, were transformed with lentiviral vectors
expressing SV40 T antigen or a combination of SVR40 T
antigen and hTERT. The immortalized cells have microglia-
like morphology and express key microglial surface markers
including CD11b, TGFβR, and P2RY12. Importantly, these
cells were confirmed to be of human origin by sequencing.
The RNA expression profiles identified by RNA-seq are also
characteristic of microglial cells. Furthermore, the cells dem-
onstrate the expected migratory and phagocytic activity, and
the capacity to mount an inflammatory response characteristic
of primary microglia. The immortalization method has also
been successfully applied to a wide range of microglia from
other species (macaque, rat, and mouse). To investigate differ-
ent aspects of HIVmolecular regulation in CNS, the cells have
been superinfected with HIV reporter viruses and latently in-
fected clones have been selected that reactive HIV in response
to inflammatory signals. The cell lines we have developed and
rigorously characterized will provide an invaluable resource
for the study of HIV infection in microglial cells as well as
studies of microglial cell function.
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Introduction
Microglial cells are the resident macrophages of the brain and
spinal cord. Because the vulnerable neural tissue is largely
shielded from leukocyte infiltrates and antibodies, microglial
cells are themajor and practically the only line of defense in the
CNS, where they perform a variety of functions which are
carried out by different cell types in the periphery. Microglia
provide tissue surveillance within the brain, searching primar-
ily for degenerating neurons, pathogens (Gehrmann et al.
1995), and apoptotic cells (Eyo and Dailey 2013). They are
also involved in cytotoxicity to fight neuronal infection by
viruses and bacteria, which can induce collateral damage to
neurons (Gehrmann et al. 1995). Although microglia are poor
antigen-presenting cells during their resting state, upon activa-
tion, they can upregulate MHC class I/II proteins and become
efficient antigen presenters to T cells infiltrating the brain in
certain inflammatory conditions (Aloisi 2001). There is also
substantial evidence that microglial cells actively participate in
synaptic stripping, tissue repair, and extracellular communica-
tion (Harry 2013). Due to their role in the CNS,microglial cells
are extremely sensitive to small physiological and pathological
changes, in part due to their specialized potassium channels
(Dissing-Olesen et al. 2007; Gehrmann et al. 1995).
The activation of microglia required to combat pathogens
in the CNS is a double-edged sword. Hyper-activation of
microglial cells can directly cause the chronic inflammation
observed during neurodegeneration, mainly due to the exces-
sive secretion of cytokines and chemokines (Streit 2006).
Many devastating neurodegenerative conditions, including
Alzheimer’s disease (Mandrekar-Colucci and Landreth
2010), Parkinson’s disease (Sanchez-Guajardo et al. 2013),
and HIV-associated dementia (HAD) (Watkins and Treisman
2015), are strongly correlated with exacerbated microglial
activation.
It is generally agreed that HIV-1 replication in the CNS is
initiated from invading perivascular macrophages, and then
progresses to infection of microglial cells and, to a lesser ex-
tent, astrocytes within the brain parenchyma (Churchill et al.
2009; Conant et al. 1994; Eugenin and Berman 2007; Gorry
et al. 2003; Hazleton et al. 2010; Watkins and Treisman 2015;
Wiley et al. 1986). HIV-1 can infect microglial cells via CD4
receptors and a variety of chemokine co-receptors including
CCR3, CCR5, and CXCR4, with CCR5 being the most
important of the three (He et al. 1997). For example, IL-4
and IL-10 facilitate entry and replication of HIV-1 in microglia
through the upregulation of CD4 and CCR5 expression, re-
spectively. HIV-associated dementia (HAD) as well as less
severe conditions known as HIV-associated neurocognitive
disorders (HAND) strongly correlates with microglia activa-
tion, presumably due to combined deleterious effects of viral
proteins and cytokines on neurons (Rock et al. 2004; Watkins
and Treisman 2015).
Here, we describe a robust method for establishing immor-
talized microglial cell lines from a wide range of species,
including humans. The immortalized cells have microglia-
like morphology, express key microglial surface markers,
demonstrate appropriate migratory and phagocytic activity,
and have the capacity to mount an inflammatory response
characteristic of primary microglia. Importantly, these cells
can be used to generate a stable cell lines latently infected with
HIV proviruses. In a related manuscript, we provide a detailed
characterization of the responses of microglial cells to inflam-
matory activation signals (Alvarez-Carbonell et al. 2016).
These extensively characterized cell lines will provide impor-
tant tools to study microglial cell function and the mechanics
and dynamics of HIV transcription in the CNS.
Methods
Isolation of primary microglial cells
Fresh CNS cortical tissue was obtained from adult patients
undergoing brain surgery at University Hospitals of
Cleveland (Human Tissue Procurement Facility, UH). Fresh
mouse brain cortical tissue was obtained from newborn mice
(CWRU). For effective manual dissociation of brain tissue, we
used the Neural Tissue Dissociation Kit (P) (Miltenyi Biotec),
following the manufacturer’s instructions. Dissociated cells
(from approximately 1 g from human tissue or 400 mg from
mouse tissue) were incubated with CD11b Microbeads
(Miltenyi Biotec) for standard magnetic cell sorting. Isolated
CD11b+ cells were then resuspended in DMEM:F12/10%
FBS medium and cultured for 7 days prior to further treat-
ment. Maturation of the primary cellular culture was moni-
tored by phase-contrast microscopy.
Infection of primary human microglia with HIV
and primary macaque microglia with SIV
Primary human microglial cells, cultured in coversli ≤ chamber
slides, were infected with replication competent R5 HIV
(AD8gNef-GFP). After 4 days, the virus was removed and
10 μM Raltegravir was added for 72 h. The cells were then
fixed (4% para-formaldehyde) and permeabilized (0.1% Triton
X-100). Cells were then stained with DAPI and Alexa Fluor®
647-conjugated phalloidin (for actin detection; ThermoFisher
Scientific), and imaged by Delta vision deconvolution micros-
copy to detect GFP expression (HIV), nuclei, and actin.
Similarly, primary macaque microglial cells, kindly provid-
ed by Dr. Janice Clements (JHU), were thawed and plated
onto coverslip chamber slides. After a week in culture, cells
were infected with replication competent SIV 17E-Fr parti-
cles. In this case, since this virus lacked the GFP-reporter,
SIV expression was measured by immunostaining for the
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SIV p27 gag protein using a SIVmac p27 monoclonal anti-
body (55-2F12; NIH AIDS Reagents Program) followed by
anti-mouse secondary-Alexa Fluor® 488-conjugated anti-
body (ThermoFisher Scientific).
Immortalization of primary microglial cells
Primary microglial cells isolated from human, macaque or
mouse brain, or cryopreserved human microglia (Sciencell,
Cat. #1900) were infected with vesicular stomatitis virus G
envelop simian virus 40 large T antigen viral particles
(VSVG SV40), containing the pBABE-puro SV40 LT con-
struct (Addgene, Plasmid #13970) by spinoculation.
Transformed microglial cells were allowed to expand in the
presence of 2 μg/mL of puromycin (selection antibiotic), and
antibiotic-resistant colonies were selected.
A fraction of the SV40-immortalized cells, as well as CHME-
5microglial cells, (Janabi et al. 1995) were superinfected VSVG
hTERT-neomycin viral particles containing the pBABE-neo-
hTERTconstruct (Addgene, Plasmid #1774) in order to express
human telomerase reverse transcriptase. Infection was also car-
ried out by spinoculation, and antibiotic-resistant colonies were
selected in the presence of 2 μg/mL puromycin and 600 μg/mL
neomycin, or 600 μg/mL neomycin in the case of CHME-5-
hTERT cells (hT-CHME-5).
Species confirmation using CycT1
DNA from immortalized human microglial cells (hμglia) was
isolated using the DNeasy Blood and Tissue Kit (Qiagen), and
the CYCT1 gene amplified using the human CYCT1-specific
primers Fwd 5′-TCC AGA ACT TCC AGT GTT GC-3′ and
Rvs 5′-TGCTTCTGGGAAATAAATGC-3′, which yields a
500-Kb product. As a control, DNA from hT-CHME-5 cells
was isolated and the CYCT1 gene amplified with the rat
CYCT1-specific primers Fwd 5′-ACA GGG AAA CAG
TCC ACC AG-3′ and Rvs 5′-TAT GAT TTA TCT GAT
AGT-3′, which yield a 400-Kb product. Similarly, CYCT1
from macaque microglial cells was amplified for purified
DNA and macaque CYCT1-specific primers Fwd 5′-ACA
GGG AAA CAG TCC ACC AG-3′ and Rvs 5′-TAT GAT
TTA TCT GAT AGT-3′. In each case, we used the Phusion
Flash High-Fidelity (ThermoFisher F548L) polymerase, and
the following PCR program: initial denaturing at 98 °C for
10 s, 30 cycles of denaturing at 98 °C for 1 s, annealing at
62 °C for 5 s, and extension at 72 °C for 15 s/Kb of product,
and a final extension step at 72 °C for 1 min.
Expression of microglial cell surface markers
Surface expression of microglia specific markers was detected
by fluorescence microscopy. Cells were cultured on glass cov-
erslips, fixed, permeabilized, and incubated for 1 h with
biotin-anti-human CD11b (BioLegend 301304), or FITC-
anti-human CD14 (BD 555397), or anti-P2RY12 (Abcam
ab86195) or biotin-anti-human P2RY12 (Bioss bs-12072R)
antibodies. Alexa Flour 647 mouse anti-GFAP (BD
Pharmingen 560298) was used as negative control. Cells were
then washed three times and incubated for 1 h with the sec-
ondary antibodies PE Streptavidin (BioLegend 405203) or
Alexa Flour® 647 goat anti-rabbit (life technologies
A21244) followed by exposure to DAPI-containing washing
solution for nuclear staining, and fluorescence exposure for
imaging.
Flow cytometry analysis (FACS) was performed using the
LSR Fortessa instrument for cell sorting, the FACSDiva soft-
ware (BD, NJ) for data collection, and the WinList 3D soft-
ware for data analysis was used to measure surface expression
of CD11b, CD14, CD68 (eBioscience 12-0689), CD16
(eBioscience 12-0167), CD32 (eBioscience 17-0329), CD64
(eBioscience 8012-0649), CD163 (eBioscience 12-1639),
P2RY12, and TGFβR (Millipore ABF17). In addition, we
also measured surface expression of CCR5 (BD 556889)
and CD4 (BD 556615) in primary astrocytes as well as clones
1A1 and C20, and monitored the expression of these receptors
across four passages (first, second, sixth, and tenth). For
FACS analysis, we used 1 × 105 cells resuspended in 1 mL
of cold PBS in the presence of 0.5 μg of the antibody for 1 h at
25 °C. Appropriate secondary antibodies were used in the
absence of fluorophore-conjugated primary antibody. Cell-
antibody complexes were centrifuged, and the pellet resus-
pended in 300 μL of PBS before FACS analysis.
Microglial cell migration and phagocytosis
Migration of hμglia cells was measured by monitoring cell
movement on the culture plate surface during a period of
10 h in time-lapse experiments, using an automated,
computer-controlled stage encoder, Leica DMI 6000B scope.
Briefly, cells were plated at a density of 2.5 × 104 cells per well
in a 24-well plate, and pictures were taken every 30 min on
pre-selected fields (8 fields total). Time-lapse movies were
produced using MetaMorph® image analysis software
(Molecular Devices, Downington, PA). The traveled distances
of all the cells within the 8 fields were averaged, and the
numbers plotted in a distance vs. time graph.
Similar time-lapse experiments were conducted in the pres-
ence of dead neuronal cells obtained after treatment of neurons
with 0.05% trypsin, followed by 1–3 min vortex, in order to
evaluate the phagocytic capacity of the hμglia cells. Cell death
was verified by propidium iodide staining; at least 90% of
cells were positive. Brightfield images were produced to count
the number of dead neuronal cells present in the field as a
function of time. The numbers were plotted in a number of
dead neurons vs. time graph.
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Cytokine production
A representative line of hμglia cells (clone C20) was untreated
or treated with TNF-α (10 pg/mL) for 16 h prior to collection
of the supernatant and isolation of total RNA (see below). The
supernatants were tested on Quansys Biosciences’s (Logan,
UT) Q-Plex Array™ kit (human) for secretion of IL-1α, IL-
1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-
15, IL-17, IL-23, IFNγ, TNF-α, TNF-β, Eotaxin, GROα,
I-309, IP-10, MCP-1, MCP-2, RANTES, TARC, Ang-2,
FGF, HGF, PDGF, TIMP-1, TIMP-2, VEGF, CD-163,
Fractalkine, GM-CSF, and TGF-β. Absolute values of detect-
ed protein secretion were quantified in picograms/milliliter,
from which the fold change expression was calculated.
RNA-seq analysis
RNA sequencing (RNA-seq) was used as a tool to profile and
confirm the microglia phenotype of clone C20, an immortal-
ized human microglia cell line, in order to further validate our
method to develop models of immortalized microglial cells.
Total cellular RNA was used for preparation of RNA-seq li-
braries using Illumina TruSeq stranded Total RNAwith Ribo
Zero Gold kit, which includes removal of both cytoplasmic
and mitochondrial ribosomal RNAs. Sequencing was per-
formed on an Illumina HiSeq 2500 instrument at a depth of
∼35 million or more paired-end, 100-bp-long, strand-specific
reads per sample. The resulting reads were quality controlled
with fastqc (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/), and low-quality reads were removed from
the library using Trim Galore (http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore/). The reads that passed
the quality filter were pseudoaligned to the Gencode V23
human transcriptome, and the reads that mapped to each
transcript were quantitated using Kallisto (Bray et al. 2016)
with 100 rounds of bootstrapping. Differential expression tests
were performed with Sleuth (http://pachterlab.github.
io/sleuth/) using the Wald test (SRA accession number
SRP075430). Differentially expressed protein-coding tran-
scripts showing twofold or more change in expression were
used in pathway analysis using the GSEA pathway analysis
tool (Subramanian et al. 2005) on the Hallmark (50 pathways
represented) and Kegg gene sets subset (186 pathways repre-
sented) of the curated gene sets (C2) collections of the
mSigDB v5 databases using 1000 permutations. Pathway
terms containing less than 2 or more than 500 genes were
eliminated from the pathway analysis. Pathways that show
enrichment with a p value <0.05 and the stringent familywise
error rate (FWER) of <0.25 were considered significant
(Subramanian et al. 2005).
Single cell RNA-seq reads from the study of human brain
cells by Darmanis et al. (Darmanis et al. 2015) was
downloaded from NCBI SRA (accession no. GSE67835).
Each file corresponding to an individual cell was checked
for quality, aligned to the transcriptome and quantitated as
described above. The alignment was performed both at the
level of individual cells and after concatenation of the files
to generate read volumes comparable to our bulk RNA-seq
to improve the accuracy of analysis in direct comparison tests.
RNA-seq reads from the analysis of mouse brain cells by
Zhang et al. (Zhang et al. 2012) were downloaded from
NCBI SRA (accession number GSE52564) and analyzed as
described above. Heatmaps were generated by means of the
Hierarchical Clustering Heatmap Python recipes (http://code.
activestate.com/recipes/578175-hierarchical-clustering-
heatmap-python/), using tpm (transcripts per million) values.
Protein-coding transcripts that were expressed at 5 tpm or
higher in at least one of the cell types under study were in-
cluded in the analyses in Fig. 8. For the middle and bottom
panels of Fig. 8a, genes with over twofold higher expression
in human and mouse neurons versus astrocytes and microglia
(middle panel) or genes enriched in astrocytes when compared
to neurons and microglia (lower panel) were selected as
neuron-enriched and astrocyte-enriched genes, respectively.
Genes enriched in C20 cells versus human oligodendrocytes
and astrocytes (middle panel) or versus human oligodendro-
cytes and neurons (bottom panel) were selected for compari-
son and their overlap with neuron- and astrocyte-specific
genes were shown as Venn diagrams.
Characterization of immortalized mouse microglial cells
Representative clonal populations of immortalized microglial
cells derived from mouse brain (muμglia) were characterized
by detection of CD11b and Iba1 protein expression as well as
by detection of CD11b, Iba1, P2RY12 and TGFβR mRNA
expression, and LPS-mediated inflammatory responses. For
immunohistochemistry, cells were plated onto glass coverslips
in a 24-well plate at a density of 100,000 cells/well. After 24 h,
cells were switched to serum-free media. Following a 10-min
fixation in 4% paraformaldehyde (PFA) with calcium and
magnesium, cells were permeabilized in PBS pH 7.4 with
0.2% Triton-X and 3% normal donkey serum (NDS) for 1 h.
Cells were blocked in PBS pH 7.4 with 3% donkey serum,
0.5% BSA and 0.2% Triton-X. Primary antibodies—rabbit
anti-Iba1 (Wako) or rat anti-CD11b (ABD Serotec)—were
added at a 1:500 dilution and cells incubated overnight at
4 °C. After washing, Alexa secondary antibodies were added
at a 1:500 dilution for 1 h at room temperature. Samples were
coverslipped using Prolong Gold and imaged on a Leica
DM5000B scope.
The constitutive expression of CD11b (Mm00434455_m1),
Iba1 (Mm00479862_g1), P2RY12 (Mm01289605_m1), and
TGFβR (Mm03024091_m1) transcripts was measured by
qPCR using the expression of each gene from one reference cell
line as control. The mRNA expression of the pro-inflammatory
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markers IL-1β (Mm00434228_m1), IL-6 (Mm00446190_m1),
and TNF-α (Mm00443258_m1) upon stimulation with 1 μg/
mL of LPS was also detected by qPCR. For this, cells were
plated in 6-well plates at a density of 500,000 cells/well and
switched to serum-freemedia after 24 h. Cells were washedwith
PBS, lysis buffer (Ambion) was added to each well, and cells
were removed using a cell scraper. Cells were passed through a
20G syringe ten times. Equal volume of 70% ethanol was added
to each sample and the Ambion® RNA purification kit used to
isolate RNA. Samples were treated with an on-column Purelink
DNase kit (Life Technologies) according to kit instructions. Five
hundred micrograms of RNAwas converted into cDNA using a
High Capacity RNA-to-cDNA kit (Applied Biosystems).
Samples were pre-amplified for genes of interest using the
Taqman Preamplification kit and gene expression assessed using
TaqmanAssays on a StepOne Plus. Gene expression levels were
measured relative to GAPDH and normalized to the reference
cell line to assess relative transcript levels across samples.
Development of HIV latency models in microglia
HIV infection of hμglia was carried out as previously de-
scribed for CHME-5 (Wires et al. 2012) to obtain clonal pop-
ulations of hμglia/HIV cells. Briefly, infection by
spinoculation was carried out with vesicular stomatitis virus
G-(VSVG) pseudotyped HIV particles bearing a fragment of
HIV-1pNL4-3, containing Tat, Rev, Env, Vpu, and Nef (some
cell lines contain an older HIV construct carrying no Nef
(Pearson et al. 2008) cloned into the pHR′ backbone together
with the reporter gene 2dE green fluorescence protein (GFP),
as previously shown (Dull et al. 1998; Pearson et al. 2008);
(Fig. 11a). The viral particles were produced by the triple
transfection of 293 T cells using lipofectamine, and the vector
titer was determined as described previously (Kim et al.
2006b). GFP+ cells were isolated 48 h post-infection by
fluorescence-activated cell sorting (FACS), further cultured,
expanded, and allowed to enter into a latent state. Evaluation
of HIV latency was performed by treatment with indicated
doses of TNF-α, IL-1β, or LPS. To keep the levels of HIV
basal expression low, cells were maintained in 1% FBS (in
DMEM supplemented with 1X normocin).
Results
Infection of primary human and macaque microglia
with HIV and SIV
Although it is generally accepted that microglial cells are ma-
jor sources of long-term HIV replication in the brain (Watkins
and Treisman 2015), only a limited number ex vivo studies of
the susceptibility of primary microglial cells to HIV infection
have been performed (Jordan et al. 1991; Lee et al. 1993). It is
particularly important to understand the susceptibility of
microglial cells to HIV infection because peripheral macro-
phages are poorly infected by HIV due restrictions imposed
by the SAMHD1 protein (Hrecka et al. 2011). To confirm that
CD11b+ cells isolated from adult human brain are a direct
target of viral infection ex vivo, primary cell cultures were
infected using replication competent R5 HIV (AD8gNef-
GFP). Our results demonstrated that HIV was expressed
(GFP fluorescence) 5 days post-viral infection, as evidenced
by high-resolution fluorescence microscopy (Fig. 1a) in ap-
proximately 75% of the cells in the culture.
In a separate experiment, infection of primary macaque
microglial cells, kindly provided by the laboratory of Janice
Clements (Baltimore, MD), by replication competent SIV
17E-Fr was also demonstrated (Fig. 1b). Similarly, expression
of SIV was detected by immunoblotting for SIV p27 gag
(green) in approximately 70% of the cells. In both experi-
ments, cell nuclei were detected by Hoescht staining of
DNA (blue), and cell shape by immunostaining for F-actin
(red). The ramified morphology of the microglial cells was
evident in both cultures (Fig. 1a, b).
Isolation and immortalization of microglial cells
from human and mouse brain
It is extremely difficult to perform molecular experiments in
primary human microglial cells due to their rarity, the difficul-
ty of obtaining surgical specimens, and their short lives in
cultures. We therefore developed protocols to obtain immor-
talized cell clones that recapitulated many of the phenotypes
of primary microglial cells.
Human microglia populations were purified from cortical
CNS tissue extracted from adult patients (Fig. 2). In three
representative isolations, we used an average of 986 mg of
tissue, yielding an average of 136 million cells, or 137 thou-
sand cells per mg (Fig. 2a), of which approximately 5.57 mil-
lion, or 4.10%, were CD11b+ cells (Fig. 2b). Mouse microglia
were purified from 4- to 6 month-old mice. Four representa-
tive isolations, averaging 215 mg of brain tissue, yielded an
average of 33 million of total cells, or 152 thousand cells per
mg (Fig. 2a), fromwhich an average of 3.11 million, or 9.42%
were CD11b+ cells (Fig. 2b). The yield of CD11b+ cells is in
close agreement to previously reported estimated fraction of
microglia in the brain (Herculano-Houzel and Lent 2005).
The vast majority of the CD11b+ cells, of both human and
mouse origin, displayed a ramified morphological phenotype
(Fig. 2c), which was accentuated with time (1 vs. 2 vs. 4 vs.
7 days). A ramified morphological phenotype is characteristic
of microglia (Kettenmann et al. 2011). Ramified microglia are
present in abundance in the brain parenchyma and constitute
approximately 10–20% of the total population of glial cells in
the adult (Banati 2003; Vaughan and Peters 1974).
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Primary microglia were transformed using either SV40 T
antigen (SV40) or SV40/hTERT. A schematic representation
of the procedure used to develop immortalized microglia is
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Fig. 2 Isolation of CD11b+ cells from brain cortical tissue. a Fresh CNS
cortical tissues from adult human patients undergoing brain surgery or
fresh mouse brain cortical tissues were used as source of brain cells. The
graph represents the average number of brain cells dissociated per
milligram of brain tissue of either human (blue) or mouse (red) origin
using the Neural Tissue Dissociation Kit (P). The error bars represent the
variation of different isolations. b Dissociated cells were incubated with
CD11b Microbeads (Miltenyi Biotec) and CD11b+ cells isolated by
standard magnetic cell sorting. The pie graphs show the proportion of
CD11b+ cells (black) in the total population of brain cells dissociated. The
CD11b+ portion shown is an average of the three isolations. c CD11b+
cells were cultured in DMEM:F12/10% FBS medium for up to 7 days
prior following treatment. The microphotographs show the visual
maturation of the primary cellular cultures followed by phase-contrast
microscopy















































Fig. 1 Infection of primary microglia cells with replication competent
HIV viruses. a Primary human microglial cells were cultured onto
coverslip chamber slides and incubated with replication competent R5
HIV (AD8gNef-GFP) for 4 days prior to viral removal and addition of
10 μM Raltegravir for 72 h. The deconvolution microscopy images are
fixed and permeabilized cells stained with DAPI and Alexa Fluor® 647-
conjugated phalloidin (for actin detection). GFP expression (HIV) is
shown in green. b Primary macaque microglial cells plated onto
coverslip chamber slides were incubated with replication competent
SIV 17E-Fr virus. SIV expression was determined by immunoblotting
for the SIV p27 gag protein using a SIVmac p27 monoclonal antibody
followed by anti-mouse secondary-Alexa Fluor® 488-conjugated
antibody
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wide range of clonal cell populations from human (hμglia
1A1, C20, and C06), mouse (muμglia 3D3, 2G6, and 1F9)
and macaque (mqμglia M1A) (Fig. 3a).
Two important observations were drawn from the immor-
talization experiments: First, immortalization-driven expan-
sion of microglial cells did not compromise the typical phe-
notype observed in primary microglia cultures, as evidenced
by the strong similar i t i res between primary and
immmortalized cells (Fig. 4a). Second, the rate of expansion
of immortalized cells was significantly diminished in the pres-
ence of hTERT, as evidenced by the slower doubling time
captured in both human and macaque microglia immortalized
with SV40 vs. SV40/hTERT (Fig. 4b). We have been unable
to expand or maintain a culture of immortalized microglial
cells using hTERT alone.
CHME-5 cells are rat cells
Currently available transformed human microglial cell lines
reported to be in use by other groups include HMC3 (Jadhav
et al. 2014; Janabi et al. 1998; Janabi et al. 1995; Rawat and
Spector 2016) and C13NJ (Martin et al. 2003). Both cell types
are direct derivations of the original CHME-5 cells (Janabi
et al. 1995), perhaps the most widely used microglial cell lines
to study important aspects of HIV neuropathogenesis (Chugh
et al. 2007; Jadhav et al. 2014; Janabi et al. 1998; Wires et al.
2012).
We have found to our surprise that CHME-5 are not human
cells, as previously believed, but actually a transformed rat
cell line. CHME-5 cells were originally created by
transfecting human fetal microglia with the large T antigen
of the simian virus 40 (SV40) (Janabi et al. 1995). We used
CHME-5 cells to investigate HIV latency in microglia, and
demonstrate cleavage of HIV proviruses by CRISPR-Cas9
(Hu et al. 2014). As we extended our studies to include
CRISPR knockouts and ChIP assays, we began to obtain se-
quence information that suggested non-human sequences
were present in the cells. Genotyping of the cells by microsat-
ellite analysis (IDEXXBioResearch) also suggested that these
cells might actually be of rat origin.
To identify the genotype of these cells unequivocally, we
studied the expression of rat and human CYCT1 as well as
SV40 T antigen using PCR assays. CYCT1, although highly
conserved across mammals, bears important sequence varia-
tions, including deletions, which we have exploited to confirm
the species of origin of the different cell clones.
As shown in Fig. 3b, distinct amplified CYCT1 fragments






































































































































































Genotyping human microglia Genotyping macaque microglia
Fig. 3 Preparation of clonal populations of microglial cells. a Schematic
representation of a typical procedure to develop a microglia clonal cell
population. Clonal populations are indicated in the colored boxes.
Primary microglia from brain of different species are isolated and
transformed with SV40 T-antigen. Clonal populations are either isolated
from the mixed population or further transformedwith hTERTantigen for
clonal isolation. b Species origin of immortalized microglia is confirmed
by amplification of the CYCT1 gene. The human CYCT1 gene is
amplified with human-specific primers only from immortalized
microglia derived from human sources (hμglia). DNA from Jurkat cells
was used a positive control. Similarly, the rat CYCT1 gene is amplified
with rat-specific primers only from cells derived from rat sources, as it is
the case of CHME-5. c CYCT1 from macaque microglial cells was
amplified for purified DNA and macaque CYCT1-specific primers. For
these experiments, the Phusion Flash High-Fidelity polymerase was used,
and the products loaded onto 1% agarose gels next to a ladder for
estimation of band size
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species. Only PCR reactions including primers designed to
target human CYCT1 gave a positive signal when DNAwas
purified from cells of human origin [hμglia (mixed pop),
hμglia (clonal pop), and Jurkat, as positive control]
(Fig. 3b). Similarly, primers designed to target CYCT1 of rat
origin (CHME-5) (Fig. 3b), or CYCT1 of macaque origin
(Macaque μglia (mixed pop) and Macaque μglia (clonal
pop); Fig. 3c) produced unique fragments.
Originally, we obtained CHME-5 cells from the laboratory
of Dr. Brandon Harvey (NIDA), with whom we published a
study using these cells (Wires et al. 2012). After identifying
these cells as rat cells, we obtained samples from laboratories
that have reported to have used CHME-5 in the past, including
those of Dr. Pierre Talbot (INRS, Canada), Dr. Marc
Desforges (UQAM, Canada), Dr. Randall Davis (Oklahoma
State University), and Dr. Jose Rodriguez (Universidad
Central del Caribe, Puerto Rico), along with another sample
from Dr. Harvey’s laboratory. All the CHME-5 cells received
from these laboratories are of rat origin, suggesting that this
was due to an early contamination of the original cell lines.
Immortalized human microglia express characteristic
surface markers
Primary microglial cells typically express P2RY12 (Butovsky
et al. 2014), which distinguishes them from peripheral macro-
phages. In agreement with this pattern of expression, we dem-
onstrate that immortalized microglial cells derived from either
fresh human brain tissue CD11b+ cells [hμglia (1A1) cells] or
commercially available primary human microglia [hμglia
(C06) cells] retained expression of CD11b (~46 and 67%,
respectively), P2RY12 (~97 and 99%, respectively), and
CD14 (~91 and 99%, respectively). In addition, these cells
were negative for GFAP (Fig. 5a), which is expressed in as-
trocytes (Jacque et al. 1978) and ependymal (Roessmann et al.
1980) cells, but not in microglia (Fig. 5b).
In contrast to what we observed in primary microglia
(Fig. 1), only a small fraction of cells (~1–5%) were infected
by wild-type HIV in both 1A1 and C20 cells. To explain this
loss of infectivity, we monitored the expression of CD4 and
CCR5, the HIV recognition receptors in microglia (Kariko
et al. 2005), in C20 cells during four sequential passages (first,
second, sixth, and tenth) (Supplementary Fig. 1). CCR5 was
detected on approximately 40% of the cells and remained
stable across passages. By contrast, CD4 expression was low
and decreasing with passage number (7.36%, first passage;
3.04%, tenth passage), consistent with the low fraction of
infected cells we have observed.
To further characterize the phenotype of the 1A1 and C06
cells, we measured surface expression of informative surface
markers by flow cytometry. As shown in Fig. 6a (1A1 cells),
CD68, which together with CD11b andCD14 is a keymarker of
brain macrophage/microglia (Graeber et al. 1990; Slepko and
Levi 1996), was present in this clone (~100%). The cells also
expressed the IgG Fc receptors, key regulators of phagocytosis
(Tuijnman et al. 1993): CD16 (~13%), CD32 (~2%), and CD64
(~96%). The presence of the Fc gamma receptors CD16, CD32,
and CD64 has been reported on microglia from both healthy
individuals and patients with neurodegenerative disorders
(Peress et al. 1993; Walker and Lue 2015). CD163, which is
specific for perivascular macrophages (Kim et al. 2006a), was
not present in this clone. Finally, TGFβR which, together with
P2RY12, is a specific marker of microglial cells (Butovsky et al.
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Fig. 4 Immortalization of
primary human microglial cells. a
A phase-contrast microscopy
photograph of human primary
microglial cells is shown next to
that of SV40- or SV40/hTERT-
transformed cells. Immortalized
microglia were allowed to expand
in the presence of 2 μg/mL of
puromycin (selection antibiotic
for SV40 T antigen) or 2 μg/mL
of puromycin plus 600 μg/mL of
neomycin (selection antibiotic for
hTERT). b The rate of expansion
of SV40- vs. SV40/hTERT-
immortalized human or macaque
cells was monitored. The graphs
represent the number of cells
counted (Y-axis) from each
culture once per day during 5 days
(X-axis)
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Quantification of these markers, together with CFAP, CD4,
and CCR5, on microglial clones 1A1 and C20 and human pri-
mary astrocytes (Fig. 6b), confirmed that GFAPwas expressed in
astrocytes, but in microglia (~90 vs. 1–3%), whereas microglial
markers were more significantly expressed in microglia, and less
so in astrocytes (CD11b ~60–65 vs. ~7%; CD14 ~65–80 vs.
~8%; CD68 ~96–98 vs. ~14%; CD16 ~13–16 vs. ~7%; CD64
~93–97 vs. ~30%; P2RY12 ~98 vs. ~ 6%; and TGFβ ~40–90 vs.
~5%). Expression of CD32 and CD163 was low (~0–3%) in
both types of cells. As noted above, the levels of CD4 in microg-
lia were practically as low as in astrocytes (~5–6 vs. ~3%), but
those of CCR5 were markedly different (~30–40 vs. ~ 2%).
DAPI CD11b CD14 MergedP2RY12
DAPI GFAP CD14 MergedP2RY12





Fig. 5 Expression of microglial
markers in immortalized cells. a
The expression of the microglial
surface markers CD11b, CD14,
and P2RY12 is shown by
fluorescence exposure imaging
(magnification ×60) in a culture
of human primary microglial
cells. b GFAP antibody, used as
negative control, stained human
astrocytes (magnification 40X).
Microglial cells cultured on glass
coverslips were fixed,
permeabilized, and incubated
with the respective antibodies for
2 h followed by washing with
DAPI-containing washing
solution for nuclear staining
























































































































































































































































































Fig. 6 Surface expression of keymarkers ofmicroglia. a Flow cytometry
analysis was used to measure the surface expression of CD11b, CD14,
CD68, CD16, CD32, CD64, CD163, P2RY12, and TGFβR on the
representative immortalized cell line hμglia 1A1. In each experiment,
100,000 cells were resuspended in 1 mL of cold PBS in the presence of
0.5 μg of the antibody or isotype control for 20 min on ice. Appropriate
secondary antibodies were used in the absence of fluorophore-conjugated
primary antibody, and the cell-antibody complexes were centrifuged and
resuspended in PBS. In each FACS profile, the gray distributions
represent the proportion of cells bound to the isotype control, whereas
the red distributions represent the proportions of cells bound by the target
antibody. b Quantification of the abovementioned markers as well as
GFAP, CD4, and CCR5 on the surface of primary human astrocytes
and immortalized microglia, as indicated
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Migration and phagocytosis of dead neuronal cells
by microglial clones
A key microglial phenotype is their ability to migrate and
phagocytose dead neurons. To evaluate how well-
immortalized microglia retain these functional features, mi-
gration was measured in a 10 h cell culture by time-lapse,
following individual cells and calculating the distance traveled
by the cell during a 30-min period of time (Fig. 7a). The
representative clones (C06 and C20) of immortalized human
microglial cells were able to migrate around the culture plate
at a speed of approximately between 20 (C06) to 27
(C20) μm/h, which appears to be similar to the migration rates
of rabbit primary microglia (Rawat and Spector 2016; Wires
et al. 2012).
We evaluated the ability of these clonal cell lines to phago-
cytose by adding dead neuronal cells to the culture media and
counting the number of dead neurons that remained every
30 min after a period of 10 h (Fig. 7b). Both clones were
capable of consuming dead neuronal cells. Interestingly, in
both cases, no reduction in the number of dead neurons was
observed during the first 2 hours, and this number precipitous-
ly fell during the next 8 h to approximately zero, suggesting a
delay in developing the cellular phagocytic machinery.
The gene expression profile of immortalized human
microglia closely resembles that of primary microglia
To further confirm the microglial phenotype of the immortal-
ized cells, clone C20 was untreated or treated with TNF-α for
16 h. The purified RNA from these cells was subjected to
RNA sequencing, while the supernatant collected was used
to quantify cytokine/chemokine secretion.
In order to determine whether the C20 cells (untreated
or TNF-α-stimulated) retain the gene expression profile
characteristic of primary microglia, the RNA-seq results
obtained in our experiment were compared to the RNA-
seq-derived gene expression patterns observed in the other
major cell types, namely astrocytes and neurons, as well
as microglia obtained from adult human temporal cortex,
as described in Darmanis et al. (2015). An additional
RNA-seq dataset that included astrocytes, neurons, and
microglia from the mouse cerebral cortex (Conant et al.
1994) was also included in the analysis. To eliminate the
biological and technical variability stemming from the
species- and donor-specific differences and the use of sin-
gle cell versus bulk RNA-seq, we defined the gene ex-
pression pattern specific to the microglia within each
dataset as genes that showed at least twofold higher ex-
pression in microglia compared to neurons and astrocytes
with a p value of less than 0.01. As we were not able to
compare the gene expression pattern of the immortalized
C20 cells with astrocytes and neurons derived from the
same donor, we compared their gene expression pattern
against pooled single-cell RNA-seq reads obtained from
human astrocytes and neurons (Darmanis et al. 2015) (see
BMethods^ section).
As shown in the Venn diagrams of Fig. 8a, microglia-
specific genes from C20 cells showed a high proportion of
overlap with the genes identified in previous analyses of hu-
man and mouse microglia (Darmanis et al. 2015). Over 100
enriched genes were shared among the three microglial cells,
including the TNF-treated C20 cells, which showed a similar
enrichment of this set of Bmicroglia-specific^ genes (Fig. 8b).
In contrast, C20 cells showedminimal overlaps with human or
mouse neurons (Fig. 8a, middle panel) or astrocytes (Fig. 8a,
lower panel, see BMethods^ section).























































 C06  C20
Fig. 7 Functional features of immortalized microglial cells. a hμglia cell
lines C06 (black) and C20 (red) were plated at a density of 1 × 105 cells
per well in a 24-well plate, and pictures were taken every 30 min on pre-
selected fields (8 fields total). Time-lapse movies were produced using
MetaMorph® image analysis software, and the distance traveled (in μm)
by a single cell was determined by adding the distance the cell traveled
along the surface. b Dead neuronal cells were added to the media of the
indicated immortalized microglial cells, and the number of neurons
remaining in the media was counted at the time points indicated. Dead
neuronal cells were obtained by treatment of neurons with 0.05% trypsin,
followed by 1–3-min vortex
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RNA-seq analysis of microglial inflammatory responses
For the RNA-seq analysis, the 1444 genes found at least two-
fold differentially expressed in C20 cells before and after treat-
ment with TNF-α were subjected to pathway analysis using
the Broad Institute software Gene Set Enrichment Analysis
(GSEA) and the mSigDB Hallmark collection (see
BMethods^).
As shown in Table 1, 6 out of the 50 gene sets were signif-
icantly (p ≤ 0.001) upregulated by TNF-α including the fol-
lowing: (i) the TNF-α signaling pathway via NF-κB
(Kaltschmidt et al. 2005), our positive control; (ii) IFN-α
(Khorooshi et al. 2015) response; (iii) IFN-γ (Tsuda et al.
2009) response; (iv) inflammatory response (Fonken et al.
2015); (v) IL6/JAK/STAT3 (Dominguez et al. 2008); and
(vi) IL2/STAT5 signaling (Sheng et al. 2014).
These gene sets, or pathways, and their major components
are character is t ic of the microgl ia l response to
neuroinflammatory stimuli (Kaminska et al. 2015). For exam-
ple, the Toll-like receptors, TLR2 and TLR3, ranked at 131
and 481 among genes upregulated in response to TNF-α,































































































































































































Cell-specific RNAs  Hierarchical Clustering
Fig. 8 Immortalized humanmicroglial gene expression profile relative to
that of other brain cells. RNA-seq was used to confirm the microglial
phenotype of the representative clone C20. The RNA-seq reads
obtained were aligned to annotated reference genomes and counted to
calculate abundance. a The relative number of identical genes (138)
expressed in C20 as well as in primary microglia of a human set (hs-
dataset) and of a mouse set (mm-dataset) was compared to the number of
overlapping genes in neurons (12) or astrocytes (16) of the same sets. b
Hierarchical clustering of genes expressed in C20 cells untreated or pre-
treated with TNF-α with respect to genes expressed in indicated cells
from the human or the mouse sets
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(Table 1). The list of genes found in each of these 6 pathways
is provided in Table 2.
In addition to the Hallmark collection, we also use the
Kyoto Encyclopedia of Genes and Genomes (KEGG) data-
base resource to confirm that pro-inflammatory pathways
characteristic of microglial cells were upregulated in TNF-α-
stimulated C20 cells. The top 6 pathways that were signifi-
cantly (p ≤ 0.003) upregulated are listed in Table 2. As expect-
ed, the top 2 pathways were our positive control pathways,
TNF-α and NF-κB signaling pathways (Kaltschmidt et al.
2005), followed by the cytokine-cytokine receptor interaction
and the chemokine pathways (Kothur et al. 2016), then the
NOD-like receptor and the TLR signaling pathways (Kigerl
et al. 2014). Activation of each one of these pathways has
been strongly implicated in neurodegenerative disorders
(Kaminska et al. 2015) (Table 2).
We were able to experimentally verify the RNA-seq results
by measuring cytokine release in response to TNF-stimula-
tion. Of the 35 cytokines/chemokines that were measured,
24 were differentially secreted between untreated and
TNF-α-treated cells (Fig. 9). The secretion of only one of
these molecules, TIMP-2, was slightly downregulated, where-
as the secretion of 13 others was upregulated between one-
and threefold. These molecules, which included IL-15, IL-1β,
IL-12p70, IL-23, IL-17, CD163, TGF-β, TIMP-1, VEGF, IL-
5, MCP-2, HGF, and Fractalkine, were classified as modestly-
induced (Fig. 9a). Moderately induced proteins, whose secre-
tion was increased between 10- and 70-fold in the presence of
TNF-α included I-309, IP-10, Eotaxin, RANTES,MCP-1, IL-
6, and GM-CSF (Fig. 9b). Highly secreted proteins included
IL-8, TNF-α, and GROα (Fig. 9c). The absolute values of
detected secreted proteins are depicted in Fig. 9d.
We also compared the expression of TNF-α-induced genes
(Fig. 8; Tables 1 and 2) with the levels of induced proteins
(Fig. 9d). We found 11 pro-inflammatory molecules for which
there was a high correlation between their induced RNA ex-
pression and protein secretion (Fig. 9e).
Immortalized murine microglial cells resemble primary
microglia
An important advantage of our method for immortalizing
microglial cells is that it is adaptable to cells from a wide
variety of species. Clones from murine cells (muμglia) were
assessed for protein expression of the myeloid cell markers
CD11b and Iba1 by immunocytochemistry (Fig. 10a). CD11b
and Iba1 transcripts were also detected in immortalized mi-
croglia by quantitative PCR (Fig. 10b). As expected, these
immortalized cells also expressed transcript levels of the
microglia-specific markers P2RY12 and TGFβR (Butovsky
et al. 2014), though expression of these genes was more var-
iable across three consecutive passage numbers (Fig. 10b).
Because microglia normally respond to LPS treatment by
producing pro-inflammatory cytokines, we measured the ex-
pression of IL-1β, IL-6, and TNF-α following LPS treatment
to assess whether microglial clones retained this functional
response. In general, the clones responded to 24 h of LPS
treatment by upregulating gene expression of these cytokines,
though this was also variable across three consecutive passage
numbers (Fig. 10c). Taken together, these results demonstrate
that the immortalized microglial clones recapitulate some as-
pects of primary cultured microglial cells.
Table 1 Sets of upregulated genes in C20 cells treated with TNF-α.
List of top six pro-inflammatory pathways with nominal p ≤ 0.001. The
number of genes of each pathway is also listed, together with a reference
as an example of the pathway’s association with microglia activation in a
neurodegenerative context
Gene sets significantly
upregulated by TNF-α in
clone C20 (GSEA analysis)
Number
of genes
Example of gene set





76 Kaltschmidt et al. 2005
INTERFERON_GAMMA_
RESPONSE
99 Tsuda et al. 2009
INTERFERON_ALPHA_
RESPONSE
66 Khorooshi et al. 2015
INFLAMMATORY_
RESPONSE
49 Fonken et al. 2015
IL6_JAK_STAT3_
SIGNALING
25 Dominguez et al. 2008
IL2_STAT5_SIGNALING 37 Sheng et al. 2014
Table 2 KEGG signaling pathways found up-regulated in C20 cells
treated with TNF-α. List of top 6 pro-inflammatory pathways with
p ≤ 0.001 for the first five pathways and p ≤ 0.003 for the last pathway.
The number of genes of each pathway is also listed, together with a
reference as an example of the pathway’s association with microglia
activation in a neurodegenerative context
Pathways significantly
upregulated by TNF-α in









37 Kaltschmidt et al. 2005
NF-KAPPA_B_
SIGNALING PATHWAY




32 Kothur et al. 2016
CHEMOKINE_
SIGNALING_PATHWAY
19 Kothur et al. 2016
NOD_LIKE_RECEPTOR_
SIGNALING_PATHWAY
13 Kigerl et al. 2014
TOLL_LIKE_RECEPTOR_
SIGNALING_PATHWAY
18 Kigerl et al. 2014
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Microglial cells latently infected by HIV are induced
to stimulate viral transcription by inflammatory agents
Finally, we have developed various clonal models for hμglia
latently infected by HIV. The hμglia cells were infected with
vesicular stomatitis virus G-(VSVG) pseudotyped lentiviral
vectors expressing Tat, Rev, Env, and Vpu, and carrying a
short-lived green fluorescence protein (d2EGFP) (Fig. 11a)
that allows monitoring of viral transcription by fluorescence-
activated flow cytometry (FACS) and/or fluorescence micros-
copy (Wires et al. 2012). Saturating concentration of TNF-α
(~94%), IL-1b (~78%), or LPS (~67%) stimulated HIV tran-
scription, as shown in Fig. 11b, in the representative clone
(HC69.5) derived from a mixed population of HIV-infected
hμglia (Fig. 3). This and other similar clonal lines (HC51,
HC56, HC61, and HC62), showing similar, but somewhat
variable response to inflammatory stimuli (Fig. 11c), have
proven valuable to study HIV latency regulation in microglia.
Discussion
HIV infection of microglial cells
It has been known since 1980s that the human brain harbors
HIV-1 primarily in multinucleated giant cells and microglia
(Kure et al. 1991; Navia et al. 1986; Sharer et al. 1986).
Microglia are the major target cell type for HIV-1 infection
in the CNS (Price et al. 1988; Takahashi et al. 1996; Watkins
et al. 1990), with CCR3 and CCR5 providing the port of entry
for macrophage-tropic viruses. Microglial cells express both
CCR3 and CCR5, and He et al. (He et al. 1997) showed that
the CCR3 ligand, eotaxin, and an anti-CCR3 antibody
inhibited HIV-1 infection of microglia, as did MIP-1β, which
is a CCR5 ligand. A similar mechanism has been described for
infection of macaque microglial cells by SIV, specifically be-
cause SIVencephalitis is associated with the active replication
of macrophage-tropic, neurovirulent viruses whose RNA pre-
dominated in the brain of macaques with encephalitis, partic-
ularly in their microglial cells (Babas et al. 2003). Early
ex vivo studies demonstrated productive infection of primary
microglia (Jordan et al. 1991; Lee et al. 1993). We have con-
firmed here that primary microglial cells isolated from either
human or macaque brain were readily infected by replication
competent HIV or SIV, respectively, and were capable of
supporting viral replication (Fig. 1). Unfortunately, the same
level of infection was not maintained in the immortalized
cells. We believed that this is the result of a significant de-
crease of CD4 expression, and not of CCR5, after transforma-
tion. There are no blocks to reverse transcription, integration
or expression in these cells since VSV-pseudotyped viruses
readily infect them. Work is in progress to derive microglial
lines that retain high levels of CD4 expression and support
HIV replication.
Immortalization of microglial cells
The extremely limited availability of primary microglial cells
and their short lives in culture has precluded us from
performing key experiments addressing fundamental






















































































































































































































































Correlation with RNA-SeqSecreted chemokines and cytokines
Fig. 9 A representative line of
hμglia, clone C20, produces
cytokines in response to
inflammatory stimuli. Clone C20
was treated with TNF-α (10 pg/
mL) for 16 h, and the supernatant
collected and tested on Quansys
Biosciences’s (Logan, UT) Q-
Plex Array™ kit (human) for
secretion of various cytokines and
chemokines. Detected protein
secretion was quantified based on
fold change expression, and its
shown in these three graphs
representing a the modestly
induced proteins (1–3-fold
change), b the moderately
induced proteins (10–70-fold
change), and c the highly induced
proteins (150–400-fold change).
d Concentration (in pg/mL) of
secreted chemokines or cytokines
in a logarithmic scale. e
Correlation of RNA expression
and protein secretion
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questions about HIV expression regulation in brain.
Compared to what we already know about the regulatory
mechanisms of HIV expression in T cells, the knowledge ac-
cumulated in the realm of HIV infection in CNS, particularly
in its regulation in microglia at the molecular level, is very
scarce. Therefore, we believe that modeling ex vivo HIV in-
fection and expression regulation in microglial cells will ac-
celerate our understanding of the molecular basis of HAD and
HAND.
The methods described here have enabled us to develop
reliable cellular models of microglia by immortalization of
primary glial cells from various species origins. In our meth-
od, we have used two immortalization agents: SV40 Tantigen
and hTERT. The SV40 T antigen, which is the most reliable
agent for the immortalization of many different cell types in
culture, works primarily by disrupting the normal function of
retinoblastoma (pRB) and p53 tumor suppressor proteins in
the cell, as well as by binding to transcriptional activators such
as p300 and CBP (Ali and DeCaprio 2001). Therefore, it is
reasonable to assume that SV40-mediated immortalization
would induce certain tumorigenic features in the transformed
cells. We therefore decided to use hTERT, alone or in combi-
nation with SV40 T antigen, to immortalize primary microg-
lia. hTERT activity results in the maintenance of sufficient
telomere lengths to avoid replicative senescence, and therefore
seems to be a cleaner method for cell transformation. Indeed,
strong evidence indicates that the hTERT enzyme can induce
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Fig. 10 Immortalized mouse
microglia displays key features of
primary microglial cells. a
Representative clonal populations
of muμglia cells, 3D3, 2G6, and




well were fixed, permeabilized,
and blocked, before incubation
with the primary antibodies
against CD11b or Iba1 at a 1:500
dilution. Alexa secondary
antibodies were added at a 1:500
dilution before mounting and
imaging. b Constitutive
expression of CD11b and Iba1
RNAwas detected in
immortalized microglia by
quantitative PCR. 500,000 cells/
well were lysed and subjected to
RNA purification followed by
cDNA synthesis prior to
amplification. The RNA sample
from clone 3D3 was used as a
reference. c Constitutive
expression of P2RY12 and
TGFβR was measured by
quantitative PCR
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cancer-associated changes or altering phenotypic properties
(Jiang et al. 1999; Lee et al. 2004; Morales et al. 1999;
Ouellette et al. 2000). Unfortunately, we have not been suc-
cessful in maintaining a transformed microglial cell line that
carries hTERT alone since the cells eventually stop growing
and die. The best scenario we have devised is to use a combi-
nation of SV40 and hTERT, which, as shown in Fig. 4, delays
the growth of the cells and leads to a less activated phenotype.
We have not observed significant differences in surface mark-
er expression between cells carrying SV40 alone, (hμglia 1A1
cells), and cells carrying both SV40 and hTERT (hμglia C06
cells) (Fig. 6).
We believe that the hμglia 1A1 cells are the first immortal-
ized human microglial cell line of cortical origin. Nagai et al.
(Nagai et al. 2005; Nagai et al. 2001) successfully immortal-
ized human microglia from embryonic telencephalon tissue
transformed by a retroviral vector encoding myc oncogene.
This cell line has been used recently to identify TMEM119
as a reliable microglial marker that discriminates resident mi-
croglia from blood-derived macrophages in the human brain
(Satoh et al. 2015).
The use of hTERT as part of the immortalization protocol
makes our lines distinctive from the previously available SV-
40-transformed human microglial cell lines, HMC3 (Jadhav
et al. 2014) and C13NJ (Martin et al. 2003), which have not
been as extensively characterized, and maybe be of rat origin,
as stated above, because they derived from CHME-5 (Fig. 3).
More recent attempts to model primary microglia without
transformation agents have been reported. For example, a
monocyte-derived microglia cell model of HIV infection
was able to recapitulate infection of primary human microglia
(Rawat and Spector 2016). A similar method was used to
develop a model of human microglia (Etemad et al. 2012).
In general, characterization of these monocyte-derived
microglial cells extensively overlapped with our cell lines.
Phenotypic characterization of microglial cell clones
Initial phenotypic characterization of our stable immortalized
cell lines included detection of characteristic markers by im-
munofluorescence and flow cytometry (Fig. 6). CD11b has
long been a marker used to identify microglia, although it is
accepted that other CNS macrophages also express CD11b
(Becher and Antel 1996; Butovsky et al. 2014; Ford et al.
1995). CD14, LPS co-receptor, is expected to be constitutive-
ly expressed in microglia (Etemad et al. 2012), and its expres-
sion has been found to increase in response to inflammation
(Beschorner et al. 2002; Zhou et al. 2013). P2RY12 and
TGFβR (Fig. 6) have been shown to be markers specific for
microglia (Butovsky et al. 2014). Another important marker
for microglia is CD68, shown to be present in our immortal-
ized lines (Fig. 6), although it can also be found in macro-
phages (Graeber et al. 1990; Slepko and Levi 1996).
Expression of CD163 is more associated with perivascular
macrophages than with microglia, although some reports sug-

















































































HIV Reactivation in Clone HC69.5















































Fig. 11 HIV emergence from
latency in human models of
infected microglia. a Genomic
organization of the HIV lentiviral
vector. A fragment of HIV-1pNL4–
3, containing Tat, Rev, Env, Vpu,
and Nef with the reporting gene
d2EGFP, is cloned into the pHR’
backbone. The resulting plasmid
was used to produce the VSVG
HIV particles, as described
previously (Kim et al. 2006b). b
Flow cytometry analysis 16 h
post-treatment using the
representative clone HC69.5.
GFP+ cell populations are
indicated in bright green, and the
percentage of GFP-expressing
cells is indicated in percentage. c
Reactivation of HIV in five
different clonal populations:
HC51, HC56, HC61, HC62, and
HC69.5. TNF-α at 50 pg/mL, IL-
1β at 100 pg/mL, and LPS at
1 ng/mL
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(Kowal et al. 2011; Roberts et al. 2004; Zhang et al. 2012).
The anti-CD163 antibody we used in our assay did not detect
the presence of CD163 on the surface of either 1A1 or C06
cells (Fig. 6). However, we were able to detect very high
levels of CD163 secreted by C20 cells, even in the absence
of stimulation by TNF-α (Fig. 8) suggesting that the propor-
tion of CD163 bound to the membrane is negligible compared
to the secreted form of the receptor.
Iba1, which has been also used as a marker of activated
macrophages/microglia (Schluesener et al. 1998; Schluesener
et al. 1999), and very recently as a read-out for activation of
microglia exposed to HIV Tat (Paris et al. 2015), was found
present in the immortalized mouse microglia (Fig. 10a, b).
Phagocytosis of dead neurons by microglial cells
Microglia exhibit pinocytotic activity and localized motility
(Booth and Thomas 1991; Fetler and Amigorena 2005;
Thomas 1992) consistent with the role of microglia as the
brain immune scavengers (Fetler and Amigorena 2005). In
CNS, microglia are highly motile, secrete inflammatory cyto-
kines, migrate to the lesion area, and phagocytose cell debris
or damaged neurons (Fu et al. 2014). We were able to verify
the motility, or migratory capacity, of the immortalized cell
lines C06 and C20 (Fig. 7). In order to determine whether the
immortalizedmicroglial cells retained their phagocytic pheno-
type, dead neurons were fed to microglia in culture. Dead
neurons were sufficient to induce phagocytosis in microglial
cells since neuronal death was induced in the absence of any
agent that could have caused microglial activation, demon-
strating that immortalized microglia retained their ability to
detect dead or damaged neurons.
The phagocytic activity observed in both C06 and C20
cells is expected since we show that immortalized microglia
highly expressed CD64, and moderately expressed CD32
(Fig. 6). We do not know whether the low expression of
CD16 detected is due to either the quality of the antibody or
to the fact that these immortalized microglial cells have low
level of this Fc receptor, since we did not test a positive control
side by side.
Inflammatory responses of microglial cells
A recently published study on primary cells originating from
adult human brain (Darmanis et al. 2015) used single-cell
RNA-Seq to classify individual cells into the major neuronal,
glial, and vascular cell types found in the brain. We took
advantage of this resource to further evaluate whether our
immortalized human microglial cells (clone C20) retained a
microglial phenotype. As shown in Fig. 8, the gene expression
profile of both untreated and TNF-α-treated C20 cells showed
strong similarities with and clustered more closely with
primary microglia than to the other brain cell types examined,
further proving evidence of their microglial origin.
The RNA-Seq experiment also revealed that an inflamma-
tory stimulus (TNF-α), induced major pro-inflammatory path-
ways (Tables 1 and 2) characteristic of macrophages and mi-
croglia, and reported to be implicated in a number of neuro-
degenerative disorders (Dominguez et al. 2008; Fonken et al.
2015; Kaltschmidt et al. 2005; Khorooshi et al. 2015; Kigerl
et al. 2014; Kothur et al. 2016; Sheng et al. 2014; Tsuda et al.
2009).
Microglial cells are a major source of cytokines and
chemokines necessary for the regulation of immune responses
in CNS. Activation of inflammatory pathways observed
through increased of transcript levels of pro-inflammatory
molecules (Fig. 8b; Tables 1 and 2) in TNF-α-stimulated
C20 cells was corroborated by the measurement of secreted
cytokines and chemokines released, another criterion we have
used to characterize our immortalized microglial cell lines.
Upon administration of pro-inflammatory stimuli, microg-
lia may release different combinations of cytokines that in-
clude interferons, interleukins, TGF-β, GM-CSF, PDGF,
EGF, FGF, IGF, NGF, neurotrophins, and BDNF (Hanisch
2002). Likewise, under inflammatory conditions, microglia
may also secrete different types of chemokines, including
MIP-1α, MIP-1β, and MCP-1 (Lee et al. 2002). As shown
in Fig. 9, stimulated C20 cells released microglia-specific key
mediators of inflammation at different levels. IL-8, which has
been reported to be increased in plasma, serum, and cerebro-
spinal fluid of HIV patients (Carrol et al. 2007; Lane et al.
2001), GROα, which is involved in neutrophil infiltration
during brain injury and inflammation (Johnson et al. 2011),
GM-CSF, which upregulates TLR4 and CD14 expression in
microglia promoting LPS-mediated inflammation in the CNS
(Parajuli et al. 2012), IL-6, which has been implicated in the
development of various neurodegenerative processes
(Spooren et al. 2011), and MCP-1, a major player in the mi-
gration and proliferation of microglia (Hinojosa et al. 2011),
were among the highest secreted molecules (Fig. 9).
Similarly, in the mouse cells, we detected activation of the
pro-inflammatory genes TNF-α, IL-1β, and IL-6 upon stim-
ulation of our microglial cells with LPS (Fig. 10d), a hallmark
of microglial cells.
Misidentification of CHME-5 cells
CHME-5 cells (Janabi et al. 1995) have been erroneously
classified as SV40-immortalized microglial cells of human
origin, even in very recent studies (Lisi et al. 2015; Wires
et al. 2012). However, genetic studies revealed that these cells
are of rat origin and do not express the SV40 T antigen
(Fig. 3b), rendering them inappropriate as a model of human
microglia. The fact that they do not carry the SV40 T antigen
suggests that the cells in circulation in numerous laboratories
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are in fact a rat glioblastoma which may have been an early
contaminant of the original cells. We have been unable to
identify any sources of CHME-5 cells that are of human
origin.
Previous studies of HIV in microglial cells (Chugh et al.
2007; Jadhav et al. 2014; Janabi et al. 1998;Martin et al. 2003;
Wires et al. 2012), including some of our own, have been
compromised because the cells were either derived from
CHME-5 or used incompletely characterized cell lines.
The risk of cross contamination between cells from differ-
ent species increases when multiple cell lines are passage in
the same laboratory. In order to avoid species cross contami-
nation, we now routinely verify the cell cultures by amplifica-
tion of the CYCT1 gene with specific primers designed to
target mouse, rat, macaque or human CYCT1.
Development of microglial cell models for HIV latency
Using these immortalized cells, we have been able establish
powerful cellular models to study HIV latency and regulation
(Fig. 11) using methods similar to those described previously
for CHME-5 cells (Wires et al. 2012). The latently infected
cells show minimal expression of HIV, but can be readily
activated by TNF-α and other stimuli. In a companion paper,
we have used these latently infected cells to show how TLR
signaling mediates HIV reactivation in microglia and how
TLR3, unlike other TLRs, plays a preponderant role in medi-
ating pathogen-induced HIV reactivation in microglia
(Alvarez-Carbonell et al. 2016).
In conclusion, we have shown here that freshly isolated
microglial cells from brain tissue can be productively infected
with HIV, can be immortalized, and after immortalization,
retain major phenotypic and functional features of primary
microglia. The repeated observations that resident brain mac-
rophages are highly susceptible to HIV infection, strongly
suggests that HIV-related neurologic disorders may be the
result of not only HIV-infected cells that infiltrated into CNS
from the periphery but also of HIV-infected microglia. The
reliable cellular models for microglial cells we report here
provide a strong experimental system to study key molecular
events associated with various microglia-related neurodegen-
erative disorders, including HAND.
Acknowledgements We thank past and present members of the Karn
laboratory: Stephanie Milne, Biswajit Das, Uri Mbonye, Kien Nguyen,
Meenakshi Shukla, Paul Wille, Amy Graham, Julia Freedman, Julian
Wong, Hongxia Mao, and Michael Greenberg for gifts of the materials,
help, and useful discussions. We also thank Kamel Khalili (Temple),
Brandon Harvey (NIDA), Kurt Hauser (VCU), and Janice Clements
(JHU) for the useful discussions and materials. We thank Scott J.
Howell (CWRU Visual Sciences) for the help with the time-lapse exper-
iments, the CWRUGenomics Core for the RNA sequencing services, and
the CWRU/UH Center for AIDS Research (P30 AI36219) for the flow
cytometry services. This work was supported by R01 DA036171 and
DP1 DA028869 (JK).
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
Ali SH, DeCaprio JA (2001) Cellular transformation by SV40 large T
antigen: interaction with host proteins. Semin Cancer Biol 11:15–23
Aloisi F (2001) Immune function of microglia. Glia 36:165–179
Alvarez-Carbonell D, Garcia-Mesa Y, Milne S, Das B, Dobrowolski C,
Rojas R, Karn J (2016). Toll-like receptor 3 activation selectively
reverses hiv latency in microglial cells retrovirology submitted
Babas T,Munoz D,Mankowski JL, Tarwater PM, Clements JE, ZinkMC
(2003) Role of microglial cells in selective replication of simian
immunodeficiency virus genotypes in the brain. J Virol 77:208–216
Banati RB (2003) Neuropathological imaging: in vivo detection of glial
activation as a measure of disease and adaptive change in the brain.
Br Med Bull 65:121–131
Becher B, Antel JP (1996) Comparison of phenotypic and functional
properties of immediately ex vivo and cultured human adult microg-
lia. Glia 18:1–10
Beschorner R, Nguyen TD, Gozalan F, Pedal I, Mattern R, Schluesener
HJ, Meyermann R, Schwab JM (2002) CD14 expression by activat-
ed parenchymal microglia/macrophages and infiltrating monocytes
following human traumatic brain injury. Acta Neuropathol 103:
541–549
Booth PL, Thomas WE (1991) Evidence for motility and pinocytosis in
ramified microglia in tissue culture. Brain Res 548:163–171
Bray NL, Pimentel H, Melsted P, Pachter L (2016) Near-optimal proba-
bilistic RNA-seq quantification. Nat Biotechnol 34:525–527
Butovsky O, JedrychowskiMP,Moore CS, Cialic R, Lanser AJ, Gabriely
G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L,
Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner
HL (2014) Identification of a unique TGF-beta-dependentmolecular
and functional signature in microglia. Nat Neurosci 17:131–143
Carrol ED,Mankhambo LA, Balmer P, Nkhoma S, Banda DL, GuiverM,
Jeffers G, Makwana N, Molyneux EM, Molyneux ME, Smyth RL,
Hart CA (2007) Chemokine responses are increased in HIV-infected
Malawian children with invasive pneumococcal disease. J Acquir
Immune Defic Syndr 44:443–450
Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B (2007)
Infection of human immunodeficiency virus and intracellular viral
Tat protein exert a pro-survival effect in a humanmicroglial cell line.
J Mol Biol 366:67–81
Churchill MJ,Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew
BJ, Gorry PR (2009) Extensive astrocyte infection is prominent in
human immunodeficiency virus-associated dementia. Ann Neurol
66:253–258
Conant K, Tornatore C, Atwood W, Meyers K, Traub R, Major EO
(1994) In vivo and in vitro infection of the astrocyte by HIV-1.
Adv Neuroimmunol 4:287–289
Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, Hayden
Gephart MG, Barres BA, Quake SR (2015) A survey of human
J. Neurovirol. (2017) 23:47–66 63
brain transcriptome diversity at the single cell level. Proc Natl Acad
Sci U S A 112:7285–7290
Dissing-Olesen L, Ladeby R, Nielsen HH, Toft-Hansen H, Dalmau I,
Finsen B (2007) Axonal lesion-induced microglial proliferation
and microglial cluster formation in the mouse. Neuroscience 149:
112–122
Dominguez E, Rivat C, Pommier B, Mauborgne A, Pohl M (2008) JAK/
STAT3 pathway is activated in spinal cord microglia after peripheral
nerve injury and contributes to neuropathic pain development in rat.
J Neurochem 107:50–60
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L
(1998) A third-generation lentivirus vector with a conditional pack-
aging system. J Virol 72:8463–8471
Etemad S, Zamin RM,RuitenbergMJ, Filgueira L (2012) A novel in vitro
human microglia model: characterization of human monocyte-
derived microglia. J Neurosci Methods 209:79–89
Eugenin EA, Berman JW (2007) Gap junctions mediate human immuno-
deficiency virus-bystander killing in astrocytes. J Neurosci 27:
12844–12850
Eyo UB, Dailey ME (2013) Microglia: key elements in neural develop-
ment, plasticity, and pathology. J NeuroImmune Pharmacol 8:494–
509
Fetler L, Amigorena S (2005) Neuroscience. Brain under surveillance:
the microglia patrol Science 309:392–393
Fonken LK, FrankMG, Kitt MM, Barrientos RM,Watkins LR,Maier SF
(2015) Microglia inflammatory responses are controlled by an in-
trinsic circadian clock. Brain Behav Immun 45:171–179
Ford AL, Goodsall AL, Hickey WF, Sedgwick JD (1995) Normal adult
ramified microglia separated from other central nervous system
macrophages by flow cytometric sorting. Phenotypic differences
defined and direct ex vivo antigen presentation to myelin basic
protein-reactive CD4+ T cells compared. J Immunol 154:4309–
4321
Fu R, Shen Q, Xu P, Luo JJ, Tang Y (2014) Phagocytosis of microglia in
the central nervous system diseases. Mol Neurobiol 49:1422–1434
Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic
immuneffector cell of the brain. Brain Res Brain Res Rev 20:269–
287
Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A,
Vesselingh SL, Purcell DF (2003) Astrocyte infection by HIV-1:
mechanisms of restricted virus replication, and role in the pathogen-
esis of HIV-1-associated dementia. Curr HIV Res 1:463–473
Graeber MB, Streit WJ, Kiefer R, Schoen SW, Kreutzberg GW (1990)
New expression of myelomonocytic antigens by microglia and
perivascular cells following lethal motor neuron injury. J
Neuroimmunol 27:121–132
Hanisch UK (2002) Microglia as a source and target of cytokines. Glia
40:140–155
Harry GJ (2013) Microglia during development and aging. Pharmacol
Ther 139:313–326
Hazleton JE, Berman JW, Eugenin EA (2010) Novel mechanisms of
central nervous system damage in HIV infection. HIV AIDS
(Auckl) 2:39–49
He J, ChenY, FarzanM, Choe H, Ohagen A, Gartner S, Busciglio J, Yang
X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D
(1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of
microglia. Nature 385:645–649
Herculano-Houzel S, Lent R (2005) Isotropic fractionator: a simple, rapid
method for the quantification of total cell and neuron numbers in the
brain. J Neurosci 25:2518–2521
Hinojosa AE, Garcia-Bueno B, Leza JC, Madrigal JL (2011) CCL2/
MCP-1 modulation of microglial activation and proliferation. J
Neuroinflammation 8:77
Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M,
Srivastava S, Florens L, Washburn MP, Skowronski J (2011) Vpx
relieves inhibition of HIV-1 infection of macrophages mediated by
the SAMHD1 protein. Nature 474:658–661
HuW, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-
Carbonell D, Garcia-Mesa Y, Karn J, Mo X, Khalili K (2014) RNA-
directed gene editing specifically eradicates latent and prevents new
HIV-1 infection. Proc Natl Acad Sci U S A 111:11461–11466
Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J, Baumann NA
(1978) Determination of glial fibrillary acidic protein (GFAP) in
human brain tumors. J Neurol Sci 35:147–155
Jadhav VS, Krause KH, Singh SK (2014) HIV-1 Tat C modulates NOX2
and NOX4 expressions through miR-17 in a human microglial cell
line. J Neurochem 131:803–815
Janabi N, Peudenier S, Heron B, Ng KH, Tardieu M (1995)
Establishment of human microglial cell lines after transfection of
primary cultures of embryonic microglial cells with the SV40 large
T antigen. Neurosci Lett 195:105–108
Janabi N, Di Stefano M, Wallon C, Hery C, Chiodi F, Tardieu M (1998)
Induction of human immunodeficiency virus type 1 replication in
human glial cells after proinflammatory cytokines stimulation: effect
of IFNgamma, IL1beta, and TNFalpha on differentiation and che-
mokine production in glial cells. Glia 23:304–315
Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, BeecheM,
Bodnar AG, Wahl GM, Tlsty TD, Chiu CP (1999) Telomerase ex-
pression in human somatic cells does not induce changes associated
with a transformed phenotype. Nat Genet 21:111–114
Johnson EA, Dao TL, Guignet MA, Geddes CE, Koemeter-Cox AI, Kan
RK (2011) Increased expression of the chemokines CXCL1 and
MIP-1alpha by resident brain cells precedes neutrophil infiltration
in the brain following prolonged soman-induced status epilepticus in
rats. J Neuroinflammation 8:41
Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M (1991) Infection of
brain microglial cells by human immunodeficiency virus type 1 is
CD4 dependent. J Virol 65:736–742
Kaltschmidt B, Widera D, Kaltschmidt C (2005) Signaling via NF-
kappaB in the nervous system. Biochim Biophys Acta 1745:287–
299
Kaminska B, Mota M, Pizzi M (2015) Signal transduction and epigenetic
mechanisms in the control of microglia activation during neuroin-
flammation. Biochim Biophys Acta
Kariko K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA
recognition by Toll-like receptors: the impact of nucleoside modifi-
cation and the evolutionary origin of RNA. Immunity 23:165–175
Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology
of microglia. Physiol Rev 91:461–553
Khorooshi R, Morch MT, Holm TH, Berg CT, Dieu RT, Draeby D,
Issazadeh-Navikas S, Weiss S, Lienenklaus S, Owens T (2015)
Induction of endogenous type I interferon within the central nervous
system plays a protective role in experimental autoimmune enceph-
alomyelitis. Acta Neuropathol 130:107–118
Kigerl KA, de Rivero Vaccari JP, DietrichWD, Popovich PG, Keane RW
(2014) Pattern recognition receptors and central nervous system
repair. Exp Neurol 258:5–16
Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J,
Williams K (2006a) CD163 identifies perivascular macrophages in
normal and viral encephalitic brains and potential precursors to
perivascular macrophages in blood. Am J Pathol 168:822–834
Kim YK, Bourgeois CF, Pearson R, Tyagi M, West MJ, Wong J, Wu SY,
Chiang CM, Karn J (2006b) Recruitment of TFIIH to the HIV LTR
is a rate-limiting step in the emergence of HIV from latency. EMBO
J 25:3596–3604
Kothur K, Wienholt L, Brilot F, Dale RC (2016) CSF cytokines/
chemokines as biomarkers in neuroinflammatory CNS disorders: a
systematic review. Cytokine 77:227–237
Kowal K, Silver R, Slawinska E, Bielecki M, Chyczewski L, Kowal-
Bielecka O (2011) CD163 and its role in inflammation. Folia
Histochem Cytobiol 49:365–374
64 J. Neurovirol. (2017) 23:47–66
Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A,
Dickson DW (1991) Human immunodeficiency virus-1 infection of
the nervous system: an autopsy study of 268 adult, pediatric, and
fetal brains. Hum Pathol 22:700–710
Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM,
Markovitz DM (2001) Interleukin-8 stimulates human immunode-
ficiency virus type 1 replication and is a potential new target for
antiretroviral therapy. J Virol 75:8195–8202
Lee SC, Hatch WC, Liu W, Kress Y, Lyman WD, Dickson DW (1993)
Productive infection of human fetal microglia by HIV-1. Am J
Pathol 143:1032–1039
Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines, and cytokine
receptors in human microglia. J Neurosci Res 69:94–103
Lee KM, Choi KH, Ouellette MM (2004) Use of exogenous hTERT to
immortalize primary human cells. Cytotechnology 45:33–38
Lisi L, Laudati E, Miscioscia TF, Dello Russo C, Topai A, Navarra P
(2015) Antiretrovirals inhibit arginase in human microglia. J
Neurochem
Mandrekar-Colucci S, Landreth GE (2010) Microglia and inflammation
in Alzheimer’s disease. CNS Neurol Disord Drug Targets 9:156–
167
Martin S, Vincent JP, Mazella J (2003) Involvement of the neurotensin
receptor-3 in the neurotensin-induced migration of human microg-
lia. J Neurosci 23:1198–1205
Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White
MA, Wright WE, Shay JW (1999) Absence of cancer-associated
changes in human fibroblasts immortalized with telomerase. Nat
Genet 21:115–118
Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim
SU (2001) Generation and characterization of immortalized human
microglial cell lines: expression of cytokines and chemokines.
Neurobiol Dis 8:1057–1068
Nagai A, Mishima S, Ishida Y, Ishikura H, Harada T, Kobayashi S, Kim
SU (2005) Immortalized human microglial cell line: phenotypic
expression. J Neurosci Res 81:342–348
Navia BA, Cho ES, Petito CK, Price RW (1986) The AIDS dementia
complex: II. Neuropathology. Ann Neurol 19:525–535
Ouellette MM, McDaniel LD, Wright WE, Shay JW, Schultz RA (2000)
The establishment of telomerase-immortalized cell lines
representing human chromosome instability syndromes. Hum Mol
Genet 9:403–411
Parajuli B, Sonobe Y, Kawanokuchi J, Doi Y, Noda M, Takeuchi H,
Mizuno T, Suzumura A (2012) GM-CSF increases LPS-induced
production of proinflammatory mediators via upregulation of
TLR4 and CD14 in murine microglia. J Neuroinflammation 9:268
Paris JJ, SinghHD, Carey AN,McLaughlin JP (2015) Exposure to HIV-1
Tat in brain impairs sensorimotor gating and activates microglia in
limbic and extralimbic brain regions of male mice. Behav Brain Res
291:209–218
Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J
(2008) Epigenetic silencing of human immunodeficiency virus
(HIV) transcription by formation of restrictive chromatin structures
at the viral long terminal repeat drives the progressive entry of HIV
into latency. J Virol 82:12291–12303
Peress NS, Fleit HB, Perillo E, Kuljis R, Pezzullo C (1993) Identification
of Fc gamma RI, II and III on normal human brain ramified microg-
lia and on microglia in senile plaques in Alzheimer’s disease. J
Neuroimmunol 48:71–79
Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988)
The brain in AIDS: central nervous system HIV-1 infection and
AIDS dementia complex. Science 239:586–592
Rawat P, Spector SA (2016) Development and characterization of a hu-
man microglia cell model of HIV-1 infection. J Neurovirol
Roberts ES, Masliah E, Fox HS (2004) CD163 identifies a unique pop-
ulation of ramified microglia in HIV encephalitis (HIVE). J
Neuropathol Exp Neurol 63:1255–1264
Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR,
Peterson PK (2004) Role of microglia in central nervous system
infections. Clin Microbiol Rev 17:942–964 table of contents
Roessmann U, Velasco ME, Sindely SD, Gambetti P (1980) Glial fibril-
lary acidic protein (GFAP) in ependymal cells during development.
An immunocytochemical study. Brain Res 200:13–21
Sanchez-Guajardo V, Barnum CJ, TanseyMG, Romero-RamosM (2013)
Neuroimmunological processes in Parkinson’s disease and their re-
lation to alpha-synuclein: microglia as the referee between neuronal
processes and peripheral immunity. ASN Neuro 5:113–139
Satoh JI, Kino Y, Asahina N, Takitani M, Miyoshi J, Ishida T, Saito Y
(2015) TMEM119 marks a subset of microglia in the human brain.
Neuropathology
Schluesener HJ, Seid K, Kretzschmar J, Meyermann R (1998) Allograft-
inflammatory factor-1 in rat experimental autoimmune encephalo-
myelitis, neuritis, and uveitis: expression by activated macrophages
and microglial cells. Glia 24:244–251
Schluesener HJ, Seid K, Meyermann R (1999) Effects of autoantigen and
dexamethasone treatment on expression of endothelial-monocyte
activating polypeptide II and allograft-inflammatory factor-1 by ac-
tivated macrophages and microglial cells in lesions of experimental
autoimmune encephalomyelitis, neuritis and uveitis. Acta
Neuropathol 97:119–126
Sharer LR, Epstein LG, Cho ES, Joshi VV, Meyenhofer MF, Rankin LF,
Petito CK (1986) Pathologic features of AIDS encephalopathy in
children: evidence for LAV/HTLV-III infection of brain. Hum
Pathol 17:271–284
ShengW,Yang F, Zhou Y, YangH, LowPY, KemenyDM, Tan P,MohA,
Kaplan MH, Zhang Y, Fu XY (2014) STAT5 programs a distinct
subset of GM-CSF-producing T helper cells that is essential for
autoimmune neuroinflammation. Cell Res 24:1387–1402
Slepko N, Levi G (1996) Progressive activation of adult microglial cells
in vitro. Glia 16:241–246
Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman
G, Gerlo S (2011) Interleukin-6, a mental cytokine. Brain Res Rev
67:157–183
Streit WJ (2006) Microglial senescence: does the brain’s immune system
have an expiration date? Trends Neurosci 29:506–510
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette
MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP
(2005) Gene set enrichment analysis: a knowledge-based approach
for interpreting genome-wide expression profiles. Proc Natl Acad
Sci U S A 102:15545–15550
Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT,
Glass JD (1996) Localization of HIV-1 in human brain using poly-
merase chain reaction/in situ hybridization and immunocytochemis-
try. Ann Neurol 39:705–711
ThomasWE (1992) Brain macrophages: evaluation ofmicroglia and their
functions. Brain Res Brain Res Rev 17:61–74
Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K
(2009) IFN-gamma receptor signaling mediates spinal microglia
activation driving neuropathic pain. Proc Natl Acad Sci U S A
106:8032–8037
Tuijnman WB, Van Wichen DF, Schuurman HJ (1993) Tissue distribu-
tion of human IgG Fc receptors CD16, CD32 and CD64: an immu-
nohistochemical study. APMIS 101:319–329
Vaughan DW, Peters A (1974) Neuroglial cells in the cerebral cortex of
rats from young adulthood to old age: an electron microscope study.
J Neurocytol 3:405–429
Walker DG, Lue LF (2015) Immune phenotypes of microglia in human
neurodegenerative disease: challenges to detecting microglial polar-
ization in human brains. Alzheimers Res Ther 7:56
Watkins CC, Treisman GJ (2015) Cognitive impairment in patients with
AIDS—prevalence and severity. HIVAIDS (Auckl) 7:35–47
Watkins BA, Dorn HH, Kelly WB, Armstrong RC, Potts BJ, Michaels F,
Kufta CV, Dubois-Dalcq M (1990) Specific tropism of HIV-1 for
J. Neurovirol. (2017) 23:47–66 65
microglial cells in primary human brain cultures. Science 249:549–
553
Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986)
Cellular localization of human immunodeficiency virus infection
within the brains of acquired immune deficiency syndrome patients.
Proc Natl Acad Sci U S A 83:7089–7093
Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M, Karn
J, Harvey BK (2012) Methamphetamine activates nuclear fac-
tor kappa-light-chain-enhancer of activated B cells (NF-
kappaB) and induces human immunodeficiency virus (HIV)
transcription in human microglial cells. J Neurovirol 18:400–
410
Zhang Z, Zhang ZY, Wu Y, Schluesener HJ (2012) Lesional accumula-
tion of CD163+macrophages/microglia in rat traumatic brain injury.
Brain Res 1461:102–110
Zhou M, Wang CM, YangWL, Wang P (2013) Microglial CD14 activat-
ed by iNOS contributes to neuroinflammation in cerebral ischemia.
Brain Res 1506:105–114
66 J. Neurovirol. (2017) 23:47–66
